🚀 Just Imagine: Reviving Extinct Species with $225 Million! 🌐 Ben Lamm, CEO of Colossal Biosciences, our portfolio company, took a giant leap in fundraising—$225M over three rounds! 🦣💸 Learn how he secured funds for the world's first de-extinction company, aiming to bring back woolly mammoths and more! 🔬 Groundbreaking Tech: Colossal uses advanced genetic tech, AI, and CRISPR to resurrect extinct species. But it's not just about mammoths—the tech has broad applications in healthcare, national security, and data analysis. 🌍 Long-Term Impact: Ben sought "patient investors" who understand the importance of preserving biodiversity. Colossal's tech is not just a venture capital issue; it's a global solution to engineering life for disease control, plastic removal, and environmental cleanup. 💡 Moonshot Thinking: Ben's advice? Pursue meaningful, moonshot endeavors fearlessly. His transition from SaaS to deep tech brought fulfillment. Colossal aims to bring new money into conservation, supporting organizations that protect endangered species. 📖 Read Ben's journey and the incredible potential of Colossal Biosciences: https://lnkd.in/d9Zj-XND #Innovation #TechInvestment #DeExtinction #Conservation #VentureCapital #ColossalBiosciences
